Related references
Note: Only part of the references are listed.Clinical applications of mass spectrometry-based proteomics in cancer: Where are we?
Emma L. Boys et al.
PROTEOMICS (2023)
EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer
Eisuke Tomiyama et al.
BRITISH JOURNAL OF CANCER (2022)
Alpha-2-macroglobulin as a novel diagnostic biomarker for human bladder cancer in urinary extracellular vesicles
Jisu Lee et al.
FRONTIERS IN ONCOLOGY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers
Eisuke Tomiyama et al.
CANCER SCIENCE (2021)
PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis
Subbroto Kumar Saha et al.
CANCER GENE THERAPY (2020)
Regulation of apoptosis by E3 ubiquitin ligases in ubiquitin proteasome system
Akshay Sharma et al.
CELL BIOLOGY INTERNATIONAL (2020)
Extracellular vesicles in urological malignancies: an update
Johannes Linxweiler et al.
NATURE REVIEWS UROLOGY (2020)
Mesenchymal Stem Cell Derived Extracellular Vesicles in Aging
Jeremy Boulestreau et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
ACO2 and ANPEP as novel prognostic markers for gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas
Ziru Liu et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging
Stefanie Hiltbrunner et al.
SCIENTIFIC REPORTS (2020)
Urinary Protein Biomarker Panel for the Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Recipients
Inge Mertens et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Bioinformatic Prediction of Gene Ontology Terms of Uncharacterized Proteins from Chromosome 11
Heeyoun Hwang et al.
JOURNAL OF PROTEOME RESEARCH (2020)
The New and the Old: Platform Cross-Validation of Immunoaffinity MASS Spectrometry versus ELISA for PromarkerD, a Predictive Test for Diabetic Kidney Disease
Scott Bringans et al.
PROTEOMES (2020)
Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine
Bert Dhondt et al.
JOURNAL OF EXTRACELLULAR VESICLES (2020)
Intercellualar Communication between Airway Epithelial Cells Is Mediated by Exosome-Like Vesicles
Richa Gupta et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)
Origins and clinical relevance of proteoforms in pediatric malignancies
Amanda Lorentzian et al.
EXPERT REVIEW OF PROTEOMICS (2019)
Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles
Eline Oeyen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Fibrin and Fibrinolysis in Cancer
Hau C. Kwaan et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
The Role of Membrane Bound Complement Regulatory Proteins in Tumor Development and Cancer Immunotherapy
Anne Geller et al.
FRONTIERS IN IMMUNOLOGY (2019)
Predictive biomarkers for drug response in bladder cancer
Takahiro Yoshida et al.
INTERNATIONAL JOURNAL OF UROLOGY (2019)
Determination of variability due to biological and technical variation in urinary extracellular vesicles as a crucial step in biomarker discovery studies
Eline Oeyen et al.
JOURNAL OF EXTRACELLULAR VESICLES (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer
Joshua W. Russo et al.
CANCER RESEARCH (2018)
Extracellular Vesicles in Bladder Cancer: Biomarkers and Beyond
Yu-Ru Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells
Giulia Cesi et al.
MOLECULAR CANCER (2018)
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
Clotilde Thery et al.
JOURNAL OF EXTRACELLULAR VESICLES (2018)
Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges
R. E. Lane et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Comparative Proteomics Analysis of Urine Reveals Down-Regulation of Acute Phase Response Signaling and LXR/RXR Activation Pathways in Prostate Cancer
Katarina Davalieva et al.
PROTEOMES (2018)
Ultrafiltration and size exclusion chromatography combined with asymmetrical-flow field-flow fractionation for the isolation and characterisation of extracellular vesicles from urine
Eline Oeyen et al.
JOURNAL OF EXTRACELLULAR VESICLES (2018)
The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2017)
NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells
Tao Tao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
UCH-L1-containing exosomes mediate chemotherapeutic resistance transfer in breast cancer
Kuan Ning et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
Jan Van Deun et al.
NATURE METHODS (2017)
Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention
Agnieszka Latosinska et al.
ONCOTARGET (2017)
Exosomes of invasive urothelial carcinoma cells are characterized by a specific miRNA expression signature
Sophie Baumgart et al.
ONCOTARGET (2017)
Exosomes as mediators of platinum resistance in ovarian cancer
Jennifer Crow et al.
ONCOTARGET (2017)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2017)
Aldolase B Overexpression is Associated with Poor Prognosis and Promotes Tumor Progression by Epithelial-Mesenchymal Transition in Colorectal Adenocarcinoma
Qingguo Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Coagulation and fibrinolysis in gastric cancer
Ombretta Repetto et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
Prospective evaluation of anxiety, pain, and embarrassment associated with cystoscopy and urodynamic testing in clinical practice
Xavier Biardeau et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2017)
The importance of regulatory ubiquitination in cancer and metastasis
L. H. Gallo et al.
CELL CYCLE (2017)
Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial-Mesenchymal Transition
Min Soon Cho et al.
JOURNAL OF IMMUNOLOGY (2016)
The biology and function of exosomes in cancer
Raghu Kalluri
JOURNAL OF CLINICAL INVESTIGATION (2016)
Exosomes play an important role in the process of psoralen reverse multidrug resistance of breast cancer
Xiaohong Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria
Kim E. M. van Kessel et al.
JOURNAL OF UROLOGY (2016)
Urinary Exosomes: The Potential for Biomarker Utility, Intercellular Signaling and Therapeutics in Urological Malignancy
Carrie A. Franzen et al.
JOURNAL OF UROLOGY (2016)
Hypercoagulation and complement: Connected players in tumor development and metastases
Silvia Guglietta et al.
SEMINARS IN IMMUNOLOGY (2016)
Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies
Ronald P. Taylor et al.
SEMINARS IN IMMUNOLOGY (2016)
Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer
Jun He et al.
ONCOTARGETS AND THERAPY (2016)
Elevated preoperative plasma fibrinogen level is an independent predictor of malignancy and advanced stage disease in patients with bladder urothelial tumors
Jikai Liu et al.
INTERNATIONAL JOURNAL OF SURGERY (2016)
NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia
Maria-Magdalena Georgescu et al.
NEOPLASIA (2016)
The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance
Bridget T. Kreger et al.
CANCERS (2016)
Proteomics in Cancer Biomarkers Discovery: Challenges and Applications
Reem M. Sallam
DISEASE MARKERS (2015)
Elevation of c-MYC Disrupts HLA Class II-Mediated Immune Recognition of Human B Cell Tumors
Jason M. God et al.
JOURNAL OF IMMUNOLOGY (2015)
Proteomics analysis of urine reveals acute phase response proteins as candidate diagnostic biomarkers for prostate cancer
Katarina Davalieva et al.
PROTEOME SCIENCE (2015)
Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma
Prashant Kumar et al.
ONCOTARGET (2015)
Handling and storage of human body fluids for analysis of extracellular vesicles
Yuana Yuana et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
The biological complexity of RKIP signaling in human cancers
Ammad Ahmad Farooqi et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Potential of Cancer Cell Derived Exosomes in Clinical Application: A Review of Recent Research Advances
Yu Sun et al.
CLINICAL THERAPEUTICS (2014)
Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
Patrick Y. Kim et al.
JOURNAL OF PROTEOMICS (2014)
Involvement of Extracellular Vesicle Long Noncoding RNA (linc-VLDLR) in Tumor Cell Responses to Chemotherapy
Kenji Takahashi et al.
MOLECULAR CANCER RESEARCH (2014)
The emerging role of extracellular vesicles as biomarkers for urogenital cancers
Muhammad Nawaz et al.
NATURE REVIEWS UROLOGY (2014)
Inflammation: an important parameter in the search of prostate cancer biomarkers
Stefania Bergamini et al.
PROTEOME SCIENCE (2014)
Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer
Yoo Hyun Song et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer
K. D. Sorensen et al.
BRITISH JOURNAL OF CANCER (2013)
Role of TSG101 in cancer
Yun Jiang et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2013)
miRNA Profiling Identifies Candidate miRNAs for Bladder Cancer Diagnosis and Clinical Outcome
Nadine Ratert et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics
Chien-Lun Chen et al.
JOURNAL OF PROTEOMICS (2013)
Proteomic analysis of podocyte exosome-enriched fraction from normal human urine
Marco Prunotto et al.
JOURNAL OF PROTEOMICS (2013)
How pure are your vesicles?
Jason Webber et al.
JOURNAL OF EXTRACELLULAR VESICLES (2013)
Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer
Paul Dowling et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responses in Vitro
Li-Hong Lv et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
Leticia Corrales et al.
JOURNAL OF IMMUNOLOGY (2012)
Comparative and Targeted Proteomic Analyses of Urinary Microparticles from Bladder Cancer and Hernia Patients
Chien-Lun Chen et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Comparative proteomic analysis for the insoluble fractions of colorectal cancer patients
Hee-Young Yang et al.
JOURNAL OF PROTEOMICS (2012)
PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma
J. R. Molina et al.
ONCOGENE (2012)
Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes
Claire Corcoran et al.
PLOS ONE (2012)
Recent advances on the role of tumor exosomes in immunosuppression and disease progression
Paola Filipazzi et al.
SEMINARS IN CANCER BIOLOGY (2012)
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
Marko Babjuk et al.
EUROPEAN UROLOGY (2011)
Implication of RAF and RKIP Genes in Urinary Bladder Cancer
Apostolos Zaravinos et al.
PATHOLOGY & ONCOLOGY RESEARCH (2011)
Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy
Chuanyu Sun et al.
PROTEOME SCIENCE (2011)
Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma
Hongjie Li et al.
PROTEOME SCIENCE (2011)
Exosome Secretion: Molecular Mechanisms and Roles in Immune Responses
Angelique Bobrie et al.
TRAFFIC (2011)
Colitis-Associated Cancer Is Dependent on the Interplay between the Hemostatic and Inflammatory Systems and Supported by Integrin alpha(M)beta(2) Engagement of Fibrinogen
Kris A. Steinbrecher et al.
CANCER RESEARCH (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Fibroblast Growth Factor Receptor 3 Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle-Invasive Bladder Cancer
Tahlita C. M. Zuiverloon et al.
CLINICAL CANCER RESEARCH (2010)
Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC)
Courtney Pollard et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2010)
Analysis of expression and structure of the TSG101 gene in cervical cancer cells
J. Broniarczyk et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2010)
Discovery of Novel Bladder Cancer Biomarkers by Comparative Urine Proteomics Using iTRAQ Technology
Yi-Ting Chen et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin
Siti S. Abdullah-Soheimi et al.
PROTEOME SCIENCE (2010)
NHERF1/EBP50 Is a New Marker in Colorectal Cancer
Yuho Hayashi et al.
NEOPLASIA (2010)
CIITA versus IFN-γ induced MHC class II expression in head and neck cancer cells
Markus Meissner et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2009)
Regulation of glutathione synthesis
Shelly C. Lu
MOLECULAR ASPECTS OF MEDICINE (2009)
Proteomic techniques identify urine proteins that differentiate patients with interstitial cystitis from asymptomatic control subjects
Maria P. Canter et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
L. M. Smith et al.
BRITISH JOURNAL OF CANCER (2008)
Brox, a novel farnesylated Bro1 domain-containing protein that associates with charged multivesicular body protein 4 (CHMP4)
Fumitaka Ichioka et al.
FEBS JOURNAL (2008)
Role of CD26/dipeptidyl peptidase IV in human T cell activation and function
Kei Ohnuma et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
The role of CD26/dipeptidyl peptidase IV in cancer
Pamela A. Havre et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Plasma proteomic analysis of patients with squamous cell carcinoma of the uterine cervix
Dae Hoon Jeong et al.
Journal of Gynecologic Oncology (2008)
Effects of Raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer
Hong Zhao Li et al.
MOLECULAR CANCER RESEARCH (2008)
Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy
Maria Teresa Rocchetti et al.
PROTEOMICS (2008)
Analysis of the urine proteome in patients with pancreatic ductal adenocarcinoma
Mark E. Weeks et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Expression of high-abundance proteins in sera of patients with endometrial and cervical cancers: Analysis using 2-DE with silver staining and lectin detection methods
Puteri S. Abdul-Rahman et al.
ELECTROPHORESIS (2007)
DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells
K. Masur et al.
REGULATORY PEPTIDES (2006)
Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors
Jens K. Habermann et al.
GASTROENTEROLOGY (2006)
Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics
SJ Callister et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Differential exoprotease activities confer tumor-specific serum peptidome patterns
J Villanueva et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
RKIP downregulates B-Raf kinase activity in melanoma cancer cells
S Park et al.
ONCOGENE (2005)
Aberrant expression of acute-phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors
SR Doustjalali et al.
ELECTROPHORESIS (2004)
CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression
N Bilalovic et al.
MODERN PATHOLOGY (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors
Z Fishelson et al.
MOLECULAR IMMUNOLOGY (2003)
Loss of CD59 expression in breast tumours correlates with poor survival
Z Madjd et al.
JOURNAL OF PATHOLOGY (2003)
Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer
SJ Freedland et al.
PROSTATE (2003)
CD10 expression is useful in the diagnosis of follicular carcinoma and follicular variant of papillary thyroid carcinoma
C Tomoda et al.
THYROID (2003)
Sensitivity and specificity of commonly available bladder tumor markers versus cytology: Results of a comprehensive literature review and meta-analyses
Y Lotan et al.
UROLOGY (2003)
Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers
CAL Ruivenkamp et al.
NATURE GENETICS (2002)
Inhibition of angiogenesis by two-chain high molecular weight kininogen (HKa) and kininogen-derived polypeptides
JC Zhang et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2002)